OCUMENSION-B: 2023 Environmental, Social and Governance Report
Apr 25 05:14 ET
OCUMENSION-B: 2023 Annual Report
Apr 25 05:05 ET
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE III CLINICAL TRIAL OF OT-502 IN CHINA
Apr 15 00:07 ET
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT COMPLETION OF THE PHASE III CLINICAL TRIAL OF OT-702 IN CHINA
Apr 8 00:00 ET
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 March 2024
Apr 3 07:37 ET
OCUMENSION-B: (I) PROPOSED AMENDMENTS TO THE 2021 SHARE OPTION SCHEME; AND (II) PROPOSED AMENDMENTS TO THE 2021 SHARE AWARD SCHEME
Mar 21 18:07 ET
OCUMENSION-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Mar 21 10:32 ET
OCUMENSION-B: VOLUNTARY ANNOUNCEMENT PRIMARY ENDPOINTS ACHIEVED IN THE PHASE II CLINICAL TRIAL OF OT-202
Mar 14 00:00 ET
OCUMENSION-B: DATE OF BOARD MEETING
Mar 7 05:53 ET
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 29 February 2024
Mar 1 03:16 ET
OCUMENSION-B: Notification Letter to Non-registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 9 03:07 ET
OCUMENSION-B: Notification Letter to Registered Shareholders and Reply Form - Arrangement of Electronic Dissemination of Corporate Communications
Feb 9 03:03 ET
OCUMENSION-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 31 January 2024
Feb 1 07:22 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 19 06:34 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 18 09:04 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 17 05:34 ET
OCUMENSION-B: DISCLOSEABLE TRANSACTION DISPOSAL OF SHARES IN EYEPOINT PHARMACEUTICALS, INC.
Jan 16 18:58 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 16 07:51 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 15 06:30 ET
OCUMENSION-B: Next Day Disclosure Return
Jan 12 05:15 ET
No Data
No Data